<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-tacrolimus.xml</id>
  <title>Recalls Watch: Tacrolimus</title>
  <link rel="self" href="https://recalls.watch/feed/substance-tacrolimus.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2025-02-05T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/96008/</id>
    <title>Astellas Pharma US Inc.: Astagraf XL and 1 more</title>
    <link href="https://recalls.watch/recall/fda/96008/"/>
    <updated>2025-02-05T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/n-astellas-pharma-us-inc-issues-voluntary-nationwide-recall-one-lot-prografr-05mg-/</id>
    <title>Astellas Pharma US, Inc. Issues Voluntary Nationwide Recall of One Lot of PROGRAF® 0.5mg (Tacrolimus) and One Lot of ASTAGRAF XL® 0.5mg (Tacrolimus Extended-Release Capsules) Because Bottles Shipped to U.S. May Contain Empty Capsules</title>
    <link href="https://recalls.watch/recall/fda/n-astellas-pharma-us-inc-issues-voluntary-nationwide-recall-one-lot-prografr-05mg-/"/>
    <updated>2024-12-23T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Bottles may contain empty capsules.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/93622/</id>
    <title>Dr. Reddy's Laboratories, Inc.: Tacrolimus Capsules</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=93622"/>
    <updated>2024-01-17T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of Foreign Tablets/Capsules: One 0.5 mg Tacrolimus capsule found in a bottle of 1 mg Tacrolimus capsules.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/91661/</id>
    <title>Dr. Reddy's Laboratories, Inc.: Tacrolimus Capsules</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=91661"/>
    <updated>2023-03-01T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of Foreign Tablets/Capsules: Presence of one Tacrolimus 1 mg capsule co-mingled in a bottle containing and labeled as Tacrolimus 0.5 mg capsules.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/90550/</id>
    <title>Glenmark Pharmaceuticals Inc., USA: Tacrolimus Ointment</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=90550"/>
    <updated>2022-08-10T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Defective Container: Tube split from side seam</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/65360/</id>
    <title>Lowlite Investments, Inc. D/B/A Olympia Pharmacy: Acetyl-D-Glucosamine w/Chondroitin 200 mg/ml and 104 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=65360"/>
    <updated>2013-07-17T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes</summary>
  </entry>
</feed>
